( May 13, 2026, 06:18 GMT | Official Statement) -- MLex Summary: A proposal by Zoetis Holdings, a wholly owned subsidiary of Zoetis Inc., to acquire the global animal genomic testing business, Neogen Genomics, from Neogen Corporation has triggered a regulatory review in Australia. In a statement on Wednesday, the Australian Competition & Consumer Commission said both Zoetis and Neogen Corporation are US-based companies that supply genomic testing services for livestock globally, including in Australia. The regulator is seeking views on the deal that will involve Zoetis acquiring all of the shares in the companies within the Neogen Corporation group that supplies genomic testing services globally, as well as certain non-Australian assets of Neogen Genomics.Statement follows. Questionnaire is attached....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.